ArticleBMC cancer2015

Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.

Naoko Honma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.